Thyroid dermopathy and acropachy

Fatourechi, Vahab

doi:10.1586/edm.10.74

Cited by 13 publications

(16 citation statements)

References 151 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…2,11 The first therapy to consider is topical corticosteroid. 2,12,13 Either a mid-potency The International Journal of Lower Extremity Wounds 13 (2) corticosteroid such as fluocinolone acetonide cream (0.2%) or high-potency corticosteroid such as clobetasol propionate may be used. 2,12 The efficacy of the treatment increases as the extent and severity of lesions decrease.…”

Section: Discussionmentioning

confidence: 99%

“…2,12,13 Either a mid-potency The International Journal of Lower Extremity Wounds 13 (2) corticosteroid such as fluocinolone acetonide cream (0.2%) or high-potency corticosteroid such as clobetasol propionate may be used. 2,12 The efficacy of the treatment increases as the extent and severity of lesions decrease. 13 The corticosteroid is directly applied to the lesion with occlusive dressing (hydrocolloid or plastic wrap) each night; the frequency of therapy may be incrementally reduced to 2 to 4 times per month after improvement is seen in 4 to 6 months.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Pretibial Myxedema

Kim

Mistry

Alavi

et al. 2014

The International Journal of Lower Extremity Wounds

View full text Add to dashboard Cite

Pretibial myxedema (PM) is a rare autoimmune manifestation of Graves' disease, which commonly presents as diffuse, nonpitting edema of shins and less often as plaques, nodules, or elephantiasis lesions mimicking lymphedema. We present a 57-year-old woman with 12-month history of PM, which occurred a year after treatment of Graves' disease and improved with topical corticosteroids, support stockings, and intralesional steroid injections until recurrence with local erythema and woody edema. A literature review was undertaken of the evidence-based treatment modalities for symptomatic PM: although commonly asymptomatic and self-limited, severe cases of PM may be treated with topical corticosteroid, compressive therapy, and intralesional corticosteroid injections.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Pretibial Myxedema

Kim

Mistry

Alavi

et al. 2014

The International Journal of Lower Extremity Wounds

View full text Add to dashboard Cite

show abstract

“…It is typically painless, causes no disability, and requires no specific therapy. 22 Localized myxedema-deposition of mucopolysaccharides in the skin-is nonpitting and firm. It typically involves the pretibial area, but can affect the hands, arms, face, ears, shoulders, back, or abdomen.…”

Section: Figurementioning

confidence: 99%

“…Treatment with plasmapheresis, cytotoxic agents, and topically applied steroids is moderately effective, but complete remission occurs in only about 10% of cases. 22,23 Heart failure in patients with hyperthyroidism is a complex problem with many facets. 24 Its mechanism and management are well described elsewhere.…”

Section: Figurementioning

confidence: 99%

“Eyeing” the Cause of Heart Failure: Visible Telltale Clues

2016

Texas Heart Institute Journal

View full text Add to dashboard Cite

“…Autoimmune manifestations of Graves’ disease include diffuse toxic goitre (95%), thyroid-associated ophthalmopathy (TAO, 25%–50%),1 pretibial myxoedema (PTM, <5%)2 and acropachy (<1%) 2. Other autoimmune disorders associated with Graves’ disease include vitiligo (>10-fold increased risk), rheumatoid arthritis (3%–5%), pernicious anaemia, coeliac disease and Addison’s disease 3.…”

mentioning

confidence: 99%